Literature DB >> 16265903

Longevity of the immune response and memory to blood-stage malaria infection.

A H Achtman1, P C Bull, R Stephens, J Langhorne.   

Abstract

Immunity to malaria develops slowly with protection against the parasite lagging behind protection against disease symptoms. The data on the longevity of protective immune responses are sparse. However, studies of antibody responses associated with protection reveal that they consist of a short- and a long-lived component. Compared with the antibody levels observed in other infection and immunization systems, the levels of the short-lived antibody compartment drop below the detectable threshold with unusual rapidity. The prevalence of long-lived antibodies is comparable to that seen after bacterial and protozoan infections. There is even less available data concerning T cell longevity in malaria infection, but what there is seems to indicate that T cell memory is short in the absence of persistent antigen. In general, the degree and duration of parasite persistence represent a major factor determining how immune response longevity and protection correlate. The predilection for short-lived immune responses in malaria infection could be caused by a number of mechanisms resulting from the interplay of normal regulatory mechanisms of the immune system and immune evasion by the parasite. In conclusion, it appears that the parasite-host relationship has developed to favor some short-lived responses, which allow the host to survive while allowing the parasite to persist. Anti-malarial immune responses present a complex picture, and many aspects of regulation and longevity of the response require further research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16265903     DOI: 10.1007/3-540-29967-x_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  37 in total

1.  Naturally acquired IgG antibodies against the C-terminal part of Plasmodium falciparum sporozoite threonine-asparagine-rich protein in a low endemic area.

Authors:  Chittakun Suwancharoen; Chaturong Putaporntip; Thanaporn Rungruang; Somchai Jongwutiwes
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

2.  Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.

Authors:  Noah H Paul; Arthur Vengesai; Takafira Mduluza; James Chipeta; Nicholas Midzi; Geetha P Bansal; Nirbhay Kumar
Journal:  Acta Trop       Date:  2016-08-01       Impact factor: 3.112

3.  Kinetics of humoral and memory B cell response induced by the Plasmodium falciparum 19-kilodalton merozoite surface protein 1 in mice.

Authors:  Mwanaidi Y Kafuye-Mlwilo; Paushali Mukherjee; Virander S Chauhan
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

Review 4.  The contribution of Plasmodium chabaudi to our understanding of malaria.

Authors:  Robin Stephens; Richard L Culleton; Tracey J Lamb
Journal:  Trends Parasitol       Date:  2011-11-17

5.  Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates.

Authors:  A Scott Muerhoff; Larry G Birkenmeyer; Ruthie Coffey; Bruce J Dille; John W Barnwell; William E Collins; Joann S Sullivan; George J Dawson; Suresh M Desai
Journal:  Clin Vaccine Immunol       Date:  2010-08-11

6.  Chronic Plasmodium chabaudi Infection Generates CD4 Memory T Cells with Increased T Cell Receptor Sensitivity but Poor Secondary Expansion and Increased Apoptosis.

Authors:  Michael M Opata; Robin Stephens
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 7.  Young lives lost as B cells falter: what we are learning about antibody responses in malaria.

Authors:  Silvia Portugal; Susan K Pierce; Peter D Crompton
Journal:  J Immunol       Date:  2013-04-01       Impact factor: 5.422

8.  Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.

Authors:  Matthew Cairns; Roly Gosling; Ilona Carneiro; Samwel Gesase; Jacklin F Mosha; Ramadhan Hashim; Harparkash Kaur; Martha Lemnge; Frank W Mosha; Brian Greenwood; Daniel Chandramohan
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

9.  Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

Authors:  I G Azcárate; P Marín-García; N Camacho; S Pérez-Benavente; A Puyet; A Diez; L Ribas de Pouplana; J M Bautista
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Modulation of autoimmunity by treatment of an infectious disease.

Authors:  Kenneth V Hyland; Juan S Leon; Melvin D Daniels; Nick Giafis; LaKitta M Woods; Thomas J Bahk; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.